Siemens' offer to buy CTI expires, subsequent offer announced

Siemens Medical Solutions USA Inc. has announced the expiration of its initial offer to acquire all of the issued and outstanding shares of CTI Molecular Imaging, Inc. on April 28th. Siemens also has announced a subsequent offer acquiring a minimum of 90 percent of CTI Molecular Imaging shares and to give all non-tendering stockholders the opportunity to participate in the offer, Siemens said.

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.